MB
Mukeshkumar Babulal Chovatiya
About Mukeshkumar Babulal Chovatiya
Data last updated:
Mukeshkumar Babulal Chovatiya is a Director at Dolphin Embro India Private Limited (since 2011), Designated Partner at Dolphin Life Science (India) Llp (since 2016) and Director at Dolphin Bioresearch Private Limited (since 2020), and holds 2 more current directorships. The companies operate in Machinery and Equipment, Healthcare and Research & Development. The 3 current companies with reported revenue have a combined latest revenue of ₹92.56 Cr; the largest is Dolphin Embro India Private Limited at ₹86.47 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 09 Jun 2011 | 2011 | ₹86.47 Cr (FY 2025) | Active | |
| Designated Partner | 07 Mar 2016 | 2016 | ₹5.37 Cr (FY 2023) | Active | |
| Director | 31 Jul 2020 | 2020 | ₹72.1 Lakh (FY 2025) | Active | |
| Director | 22 Aug 2020 | 2020 | Active | ||
| Director | 02 Jan 2015 | 2015 | Active |
Board colleagues of Mukeshkumar Babulal Chovatiya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mahendrabhai Gangdasbhai Sidpara | 03536203 | Dolphin Embro India Private Limited | Director |
| Ruchit Bhupatbhai Ramolia | 07981199 | Dolphin Life Science (India) Llp | Designated Partner |
| Sonalben Mukeshkumar Chovatiya | 06392654 | Dolphin Bioresearch Private Limited | Director |
| Jayvirsinh Chudasama | 08844077 | Vaidik Ayurved Research Private Limited | Director |
| Sharad Labhubhai Miyani | 08844078 | Vaidik Ayurved Research Private Limited | Director |
| Sanjay Babulal Chovatia | 02879383 | Dolphin Scientific (India) Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mukeshkumar Babulal Chovatiya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mukeshkumar Babulal Chovatiya
Mukeshkumar Babulal Chovatiya currently holds 5 directorships: Dolphin Embro India Private Limited (Director, since 09 Jun 2011, revenue ₹86.47 Cr (FY 2025)); Dolphin Life Science (India) Llp (Designated Partner, since 07 Mar 2016, revenue ₹5.37 Cr (FY 2023)); Dolphin Bioresearch Private Limited (Director, since 31 Jul 2020, revenue ₹72.1 Lakh (FY 2025)); Vaidik Ayurved Research Private Limited (Director, since 22 Aug 2020); Dolphin Scientific (India) Private Limited (Director, since 02 Jan 2015).
Mukeshkumar Babulal Chovatiya was first appointed on 09 Jun 2011 as Director at Dolphin Embro India Private Limited. The most recent appointment on record is 22 Aug 2020 at Vaidik Ayurved Research Private Limited.
The 3 current companies of Mukeshkumar Babulal Chovatiya that report revenue have a combined latest revenue of ₹92.56 Cr: Dolphin Embro India Private Limited ₹86.47 Cr (FY 2025); Dolphin Life Science (India) Llp ₹5.37 Cr (FY 2023); Dolphin Bioresearch Private Limited ₹72.1 Lakh (FY 2025).
The current boards of Mukeshkumar Babulal Chovatiya's companies include Mahendrabhai Gangdasbhai Sidpara (Dolphin Embro India Private Limited), Ruchit Bhupatbhai Ramolia (Dolphin Life Science (India) Llp), Sonalben Mukeshkumar Chovatiya (Dolphin Bioresearch Private Limited), Jayvirsinh Chudasama (Vaidik Ayurved Research Private Limited), Sharad Labhubhai Miyani (Vaidik Ayurved Research Private Limited), Sanjay Babulal Chovatia (Dolphin Scientific (India) Private Limited).